By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RheoGene, Inc. 

2650 Eisenhower Avenue

Norristown  Pennsylvania  19403  U.S.A.
Phone: 610-650-8734 Fax: 610-650-8755




Company News
RheoGene, Inc. Merger With Intrexon Corporation Creates Biotech Firm Targeting Gene-Based Therapies 12/19/2006 1:58:17 PM
RheoGene, Inc. To Participate In CNS Focus Session At Eighth Annual Biotechnology Industry Organization (BIO) CEO And Investor Conference 2/13/2006 3:43:51 PM
RheoGene, Inc. Grants Ichor Medical Systems, Inc. A Commercial License To Develop A Regulated Gene Therapy For Multiple Sclerosis Using The RheoSwitch® Therapeutic System 2/9/2006 2:09:51 PM
CHEMICON International, Inc. (SERO) Enters Into License Agreement With RheoGene, Inc. 11/28/2005 1:19:36 PM
RheoGene, Inc. And TissueGene Inc. Sign Collaborative Agreement For Bone Regeneration And Repair10/19/2005 5:13:13 PM
RheoGene, Inc. And New England Biolabs, Inc. Sign Licensing Agreement For RheoSwitch(TM) Research Kits10/19/2005 5:11:43 PM
J. Mark Braughler Joins RheoGene, Inc. As Vice President Of Therapeutics10/19/2005 5:11:31 PM
RheoGene, Inc. Introduces AttSite(TM) Recombinases10/19/2005 5:10:20 PM
RheoGene, Inc. Grants Xenogen Corporation (XGEN) A License To Develop RheoMice™ Transgenics10/19/2005 5:09:20 PM
RheoGene, Inc. Adds Internationally Renowned Gene Therapy Experts To Its Scientific Advisory Board10/19/2005 5:09:04 PM